Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Immunity
|
March 18, 2008
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes
Nathalie Demotte, Vincent Stroobant, Pierre J Courtoy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 9, 2005
Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein
Yi Zhang, Zhaojun Sun, Hugues Nicolay, et al.
Science (New York, N.Y.)
|
September 9, 2006
An antigen produced by splicing of noncontiguous peptides in the reverse order
Edus H Warren, Nathalie J Vigneron, Marc A Gavin, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
Marie Solvay, Pauline Holfelder, Simon Klaessens, et al.
Nature Chemical Biology
|
June 14, 2016
A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast
François Collard, Francesca Baldin, Isabelle Gerin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2022
A case of convergent evolution: Several viral and bacterial pathogens hijack RSK kinases through a common linear motif
Frédéric Sorgeloos, Michael Peeters, Yohei Hayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2017
Nit1 is a metabolite repair enzyme that hydrolyzes deaminated glutathione
Alessio Peracchi, Maria Veiga-da-Cunha, Tomiko Kuhara, et al.
European Journal of Medicinal Chemistry
|
March 23, 2011
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, et al.
Bioorganic & Medicinal Chemistry
|
January 29, 2011
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Novel H-2D<sup>b</sup>-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice
James McAuliffe, Silvia Panetti, Emily Steffke, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Immunity
|
March 18, 2008
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes
Nathalie Demotte, Vincent Stroobant, Pierre J Courtoy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 9, 2005
Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein
Yi Zhang, Zhaojun Sun, Hugues Nicolay, et al.
Science (New York, N.Y.)
|
September 9, 2006
An antigen produced by splicing of noncontiguous peptides in the reverse order
Edus H Warren, Nathalie J Vigneron, Marc A Gavin, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
Marie Solvay, Pauline Holfelder, Simon Klaessens, et al.
Nature Chemical Biology
|
June 14, 2016
A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast
François Collard, Francesca Baldin, Isabelle Gerin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2022
A case of convergent evolution: Several viral and bacterial pathogens hijack RSK kinases through a common linear motif
Frédéric Sorgeloos, Michael Peeters, Yohei Hayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2017
Nit1 is a metabolite repair enzyme that hydrolyzes deaminated glutathione
Alessio Peracchi, Maria Veiga-da-Cunha, Tomiko Kuhara, et al.
European Journal of Medicinal Chemistry
|
March 23, 2011
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, et al.
Bioorganic & Medicinal Chemistry
|
January 29, 2011
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Novel H-2D<sup>b</sup>-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice
James McAuliffe, Silvia Panetti, Emily Steffke, et al.
Page
of 9